Sebia, provider of protein electrophoresis and tests for the diagnosis of hemoglobin disorders, has announced the debut of its Hemoglobins Atlas. This tool is dedicated to helping the company’s capillary electrophoresis users orientate their diagnosis of hemoglobinopathies.
Hemoglobin electrophoresis is an established technique routinely used for screening samples for hemoglobinopathies. The assay is based on the principle of capillary electrophoresis in free solution. Sebia’s capillary electrophoresis technology allows separation of hemoglobin fractions and detection of the major hemoglobin variants and thalassemia patterns. Capillary electrophoresis is used as a first-line screening method.
To mark the tenth year of this Sebia technology, the company has developed the Hemoglobins Atlas as a go-to reference compendium. Company representatives say that, as an interactive educational CD-rom, the Atlas will help laboratories to increase their diagnostic knowledge of hemoglobinopathies. The Atlas is dedicated to the Sebia customers who use the Capillarys and Minicap instruments. The instruments perform sequences automatically, from sampling to final clear-cut profile, with quantification, separation, and presumptive identification of the most common hemoglobins.
Piero Giordano, PhD, of Leiden University Medical Center in the Netherlands, has collaborated as scientific counselor on all of the research data. He also helped to develop the content. “As an interactive educational aid, the Atlas will cover as many variants as possible, from common to rare and in variable genotype combinations,” says Professor Giordano. “Presumed risk information is also included. If a lab result ends up in the files without any preventive follow-up, the diagnostic efforts of the lab will have been wasted. For this reason we are now sharing all of the relevant confirmed and frequent patterns that are associated with severe diseases.” Learn more about products provided by Sebia Electrophoresis.
Read more
